Medici per Adenocarcinoma del sigma all'estero — Pagina 3

Il professor Keil è specializzato in radiologia diagnostica e interventistica, con una vasta esperienza in imaging RM e TC per interventi medici complessi.

• Laureato con lode presso la Julius-Maximilians-Universität di Würzburg
• Formazione sotto la guida del rinomato Professor Rolf W. Günther presso l'Ospedale Universitario di Aachen
• Primario di Radiologia Diagnostica e Interventistica presso l'Ospedale Accademico di Solingen
• Esperto in diagnostica per immagini a sezione trasversale e diagnostica ecografica

Il medico è un immunologo con oltre 30 anni di esperienza, specializzato in viroterapia, un campo all'avanguardia nell'immunologia. <\/p>

Si è laureato presso l'Istituto Medico di Riga e ha completato un tirocinio in Medicina Interna. <\/p>

Attualmente è il capo del Centro di Immunologia Clinica presso l'Ospedale Universitario Clinico Pauls Stradins.<\/p>

Il medico si è laureato presso la Facoltà di Medicina dell'Università Ebraica nel 1987 e si specializza in Chirurgia e Chirurgia Colorettale. Affiliato al Centro Medico Hadassah, il medico è Istruttore in Chirurgia dal 1995, Docente dal 1999 e Docente Senior dal 2005. Il medico dirige il Programma per Studenti di Medicina nel Dipartimento di Chirurgia dal 1997 ed è Direttore del Programma di Residenza nel Dipartimento di Chirurgia dal 2000. Certificato in Chirurgia Generale in Israele dal 1998, il medico è anche membro di varie associazioni chirurgiche.<\/p>

Dr. Nail Paksoy is an associate professor of medical oncology at Medipol Bahçelievler Hospital. He is board-certified by the European Society for Medical Oncology (ESMO). Dr. Paksoy specializes in lung, breast, and gastrointestinal cancers. He uses modern immunotherapy and targeted therapy protocols. His clinic is JCI-accredited for high safety standards.

• Served as a subinvestigator in over 8 international clinical trials for Roche and Pfizer.
• Authored over 40 research articles in journals indexed by SCI and SSCI.
• Completed dual fellowships in allergy-immunology and medical oncology.
• Treats complex sarcomas and renal cell carcinomas with systemic therapies.

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Education

Ondokuz Mayıs University Faculty of Medicine (1991)

KTÜ Faculty of Medicine Farabi Hospital (Specialization.1998)

Istanbul University Çapa Faculty of Medicine (Laparoscopic Surgery Training, 2002)

Istanbul University Çapa Faculty of Medicine (Laparoscopic Antireflux Surgery Training, 2006)

Istanbul University Cerrahpaşa Faculty of Medicine (General Surgery Clinic Advance Laparoscopic Surgery, Laparoscopic Bariatric Surgery, Morbid Obesity and Oncological Cancer Surgery Training, 2010i)

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Il medico è un oncochirurgo con 25 anni di esperienza, specializzato nel trattamento del cancro del retto e del colon, chirurgia bariatrica e trattamento del cancro esofageo.<\/p>

Con oltre 15.000 procedure chirurgiche eseguite, il medico esegue più di 1.000 interventi chirurgici minimamente invasivi all'anno, utilizzando tecniche laparoscopiche e robotiche.<\/p>

Membro di società mediche internazionali, il medico è presidente dell'Associazione dei Chirurghi-Endoscopisti in Europa e tiene conferenze sulle tecniche chirurgiche avanzate e la laparoscopia.<\/p>

Riconosciuto come pioniere nella chirurgia gastrointestinale, il medico è stato il primo a eseguire procedure rivoluzionarie come la rimozione della cistifellea attraverso la bocca e la prima escissione totale del mesoretto transanale (TaTME).<\/p>

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Thomas W Kraus is the Chief Physician at Nordwest Clinic in Frankfurt. He has performed over 3,000 surgical interventions for bowel and gastrointestinal diseases. Dr. Kraus specializes in the Whipple procedure, stomach oncology, and hepatobiliary surgery. He trained at world-renowned centers like Johns Hopkins and Memorial Sloan Kettering.

• Specialist in pancreatic surgery and reconstruction of the bile ducts.
• Founder and Director of the German Society “Art of surgery.”
• Nationally ranked among the best physicians in Germany by Focus magazine.
• Fellow of the American College of Surgeons (FACS).

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Il medico è un oncologo altamente qualificato specializzato sia in oncologia medica che in oncologia radioterapica. Laureato presso la Scuola di Medicina di Firenze in Italia, il medico è certificato in Israele e ha completato diversi corsi avanzati, tra cui l'Esame del Consiglio della Comunità Europea in Medicina e il corso di insegnamento ESTRO sulle tecniche moderne di brachiterapia.<\/p>

Con una vasta esperienza professionale, il medico ha servito come medico senior e capo dei servizi oncologici in varie istituzioni. Attualmente, il medico dirige il Servizio di Malattie Maligne Gastrointestinali ed è responsabile del Dipartimento di Radioterapia presso il Centro Medico Rambam a Haifa, Israele.<\/p>

Il medico è un oncochirurgo altamente qualificato con vasta esperienza in oncologia chirurgica. Specializzandosi nel trattamento di casi complessi di cancro, ha eseguito con successo numerosi interventi oncologici avanzati. Il medico è riconosciuto per la sua competenza nelle tecniche minimamente invasive, contribuendo a migliorare i risultati dei pazienti e i tempi di recupero. Con un impegno per la ricerca e l'innovazione, ha pubblicato diversi articoli influenti su riviste mediche di primo piano. Il medico è anche attivamente coinvolto in studi clinici mirati allo sviluppo di trattamenti oncologici all'avanguardia.<\/p>

Il medico è specialista in chirurgia endoscopica, con vasta esperienza in procedure minimamente invasive. Ha contribuito significativamente ai progressi nelle tecniche chirurgiche e ha pubblicato numerosi articoli su riviste peer-reviewed. Il medico è certificato e riconosciuto per l'eccellenza nella cura del paziente e nei risultati chirurgici.<\/p>

Laureato in una prestigiosa scuola di medicina, il medico ha completato una borsa di studio in tecniche endoscopiche avanzate. È attivamente coinvolto nell'insegnamento e nel tutoraggio di studenti di medicina e specializzandi, migliorando il futuro dell'educazione chirurgica.<\/p>